High levels of N6AMT1 are associated with multiple forms of cancers, and small interfering RNAs to N6AMT1 prevent the proliferation of cancer cells from androgen receptor–dependent and castration-resistant prostate cancer (27), bladder cancer (60, 61), colorectal cancers (62), as well as small cell and non–small cell lung cancer (28). Here, AR is linked to urinary bladder carcinoma.